
Keywords: اسید آراشیدونیک; AA; arachidonic acid; AERD; aspirin exacerbated respiratory disease; BAL; bronchoalveolar lavage; CF; cystic fibrosis; CRSsNP; chronic rhinosinusitis without nasal polyps; CRSwNP; chronic rhinosinusitis with nasal polyps; ILC2; type 2 innate lymphocytes;